Bridging the gap by providing access to oncology care to rural communities: A hybrid delivery model combining in-person visits with Telehealth von Rariy, Chevon, Truesdale, Lynn, Ahn, Eugene R., Gershenhorn, Bruce G., Easthon, Katie, Garoutte, Bethany, Govorchin, Pete, Schink, Julian C.

Volltext

The role of next-generation sequencing (NGS) to integrate identified genomic alterations (GA) into cancer treatment decisions in gastrointestinal (GI) tumors von Kundranda, Madappa N., Braun, Donald Peter, Kramer, Kim, Staren, Edgar Donald, Tan, Brad, Gershenhorn, Bruce G., Klimant, Eiko, Randolph, Brion Vincent, Markman, Maurie

Volltext

BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy von Klempner, Samuel J, Gershenhorn, Bruce, Tran, Phu, Lee, Thomas K, Erlander, Mark G, Gowen, Kyle, Schrock, Alexa B, Morosini, Deborah, Ross, Jeffrey S, Miller, Vincent A, Stephens, Philip J, Ou, Sai-Hong Ignatius, Ali, Siraj M

Volltext

Mo1885 - Use of Infliximab in the Treatment of Nivolumab-Induced Refractory Colitis in Patients with Advanced Non-Small Cell Lung Cancer von Prakash, Ravi K., Abboud, Elham, Gershenhorn, Bruce, Gupta, Digant, Vashi, Pankaj G.

Volltext

Use of Infliximab in the Treatment of Nivolumab-Induced Refractory Colitis in Patients with Advanced Non-Small Cell Lung Cancer von Prakash, Ravi K, Abboud, Elham, Gershenhorn, Bruce, Gupta, Digant, Vashi, Pankaj G

Volltext

BRAF V600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF–MEK Combination Therapy von Klempner, Samuel J., Gershenhorn, Bruce, Tran, Phu, Lee, Thomas K., Erlander, Mark G., Gowen, Kyle, Schrock, Alexa B., Morosini, Deborah, Ross, Jeffrey S., Miller, Vincent A., Stephens, Philip J., Ou, Sai-Hong Ignatius, Ali, Siraj M.

Volltext